2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Biliary Atresia in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Biliary Atresia: Progressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, Y | 1 |
| Wang, J | 1 |
| Chen, Y | 1 |
| Zhou, K | 1 |
| Wen, J | 1 |
| Wang, Y | 1 |
| Zhou, Y | 1 |
| Pan, W | 1 |
| Cai, W | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Biliary Atresia
| Article | Year |
|---|---|
Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling.
Topics: Biliary Atresia; Cell Line; Cell Movement; Cell Proliferation; Chromones; DNA-Binding Proteins; Down | 2014 |